CAT: A Protein Involved in Neurodegenerative Diseases (G847)

Target Name: CAT

NCBI ID: G847

Content of Review Report on CAT Target / Biomarker

CAT

Other Name(s): CATA_HUMAN | catalase | Catalase | OTTHUMP00000041455 | epididymis secretory sperm binding protein

CAT: A Protein Involved in Neurodegenerative Diseases

CAT (Cata_Human) is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease. It is a potential drug target for these diseases and has been shown to interact with several key proteins involved in the development of these diseases.

CAT is a transmembrane protein that is expressed in the brain and is involved in several signaling pathways that are important for the development and progression of neurodegenerative diseases. One of the main functions of CAT is to regulate the levels of neurotransmitters, such as dopamine and glutamate, in the brain. These neurotransmitters play a crucial role in the function of the brain and are involved in a wide range of cognitive processes, including motivation, pleasure, and memory.

CAT is also involved in the regulation of the stress response to stress, which is a key factor in the development of neurodegenerative diseases. Studies have shown that CAT plays a role in the regulation of the stress response and that alterations in the stress response have been linked to the development of these diseases.

In addition to its role in neurotransmission and stress response, CAT is also involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. This is important for the development and progression of neurodegenerative diseases, as changes in synaptic plasticity can contribute to the development of these diseases.

CAT has also been shown to interact with several key proteins that are involved in the development and progression of neurodegenerative diseases. One of the most well-studied of these proteins is the protein Tau, which is involved in the regulation of the stress response and is a key protein in the development of Alzheimer's disease. Studies have shown that CAT interacts with Tau and that alterations in the level of CAT can affect the levels of Tau in the brain.

Another protein that has been shown to interact with CAT is the protein Phospho-ABC protein, which is involved in the regulation of synaptic plasticity. Studies have shown that CAT interacts with Phospho-ABC protein and that alterations in the level of CAT can affect the levels of Phospho-ABC protein in the brain.

In conclusion, CAT is a protein that is involved in several key signaling pathways that are important for the development and progression of neurodegenerative diseases. Its role in neurotransmission, stress response, and synaptic plasticity makes it a potential drug target for these diseases. Further research is needed to fully understand the role of CAT in the development and progression of these diseases and to identify potential therapeutic approaches.

Protein Name: Catalase

Functions: Catalyzes the degradation of hydrogen peroxide (H(2)O(2)) generated by peroxisomal oxidases to water and oxygen, thereby protecting cells from the toxic effects of hydrogen peroxide (PubMed:7882369). Promotes growth of cells including T-cells, B-cells, myeloid leukemia cells, melanoma cells, mastocytoma cells and normal and transformed fibroblast cells (PubMed:7882369)

The "CAT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets